Affiliation:
1. Department of Microbiology, Hospital La Fe, Valencia, Spain
2. Dirección General de Salud Publica, Valencia, Spain
3. Universidad CEU San Pablo, Valencia, Spain
4. Universitat de València, Valencia, Spain
Abstract
ABSTRACT
Escherichia coli
and the antimicrobial pressure exerted on this microorganism can be modulated by factors dependent on the host. In this paper, we describe the distribution of antimicrobial resistance to amikacin, tobramycin, ampicillin, amoxicillin clavulanate, cefuroxime, cefoxitin, cefotaxime, imipenem, ciprofloxacin, fosfomycin, nitrofurantoin, and trimetoprim-sulfametoxazole in more than 100,000
E. coli
isolates according to culture site and patient age, gender, and location. Bayesian inference was planned in all statistical analysis, and Markov chain Monte Carlo simulation was employed to estimate the model parameters. Our findings show the existence of a marked difference in the susceptibility to several antimicrobial agents depending on from where
E. coli
was isolated, with higher levels of resistance in isolates from medical devices, the respiratory system, and the skin and soft tissues; a higher resistance percentage in men than in women; and the existence of a clear difference in antimicrobial resistance with an age influence that cannot be explained merely by means of an increase of resistance after exposure to antimicrobials. Both men and women show increases in resistance with age, but while women show constant levels of resistance or slight increases during childbearing age and greater increases in the premenopausal age, men show a marked increase in resistance in the pubertal age. In conclusion, an overwhelming amount of data reveals the great adaptation capacity of
E. coli
and its close interaction with the host. Sex, age, and the origin of infection are determining factors with the ability to modulate antimicrobial resistances.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference39 articles.
1. Alós, J. I., P. García-Peña, and J. Tamayo. 2007. Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections. Rev. Esp. Quimioter. 20:211-215. (In Spanish.)
2. Antão, E. M., L. H. Wieler, and C. Ewers. 2009. Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog. 1:22.
3. Differential Effects of Epinephrine, Norepinephrine, and Indole on
Escherichia coli
O157:H7 Chemotaxis, Colonization, and Gene Expression
4. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location
5. Bukh, A. S., et al. 2009. Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J. Antimicrob. Chemother. 64:163-168.